Ono Venture Investment
Profile and portfolio
Ono Venture Investment is the corporate venture arm of Ono Pharmaceutical Co., Ltd., a pharmaceutical and biotech company. It was founded in 2020 and is based in Cambridge, United States. It invests from seed to Series A. Sectors it names: biotech and life sciences.
Every figure links to its source
Snapshot
Where it invests and who leads it
Geography
- Headquarters
- Cambridge, United States
- Offices
- Cambridge, United States
- Osaka, Japan
Investment regionsS5S2
LeadersS1
- Shunichiro MatsumotoPresident & CEOFind on LinkedInFirm page
- Daisuke NakayamaVice PresidentFind on LinkedInFirm page
- Kousuke TaniSenior Investment DirectorFind on LinkedInFirm page
- Ryohei MiyataInvestment DirectorFind on LinkedInFirm page
- Hiroshi YamamotoInvestment/Operation Senior AdvisorFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Ono Pharmaceutical Co., Ltd. | Single source | S2 |
| Parent industry | Pharmaceuticals and biotech | Single source | S2 |
| Founded | 2020 | Single source | S4 |
| Headquarters | Cambridge, United States | Single source | S1 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S2 |
| Stages | Seed, Series A | Reported by BIO Investment & Growth Summit 2026: Ono Venture Investment profile | S5 |
Portfolio
The firm's portfolio page lists 12 companies.S3
Every company on the Ono Venture Investment list
12 companies, as listed on the firm's own website.S3 Read the firm's list.
- AIRNA
- Alchemab Therapeutics
- Arbor Biotechnologies
- Casma Therapeutics
- Harness Therapeutics
- Immunitas Therapeutics
- Mediar Therapeutics
- Mission BioCapital Platinum Program
- Mozart Therapeutics
- Photys Therapeutics
- Switch Therapeutics
- United Immunity
Official pages
Read the firm's own pages for current information.
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Ono Venture Investment or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.